1. Home
  2. POET vs INVA Comparison

POET vs INVA Comparison

Compare POET & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

SELL

Current Price

$8.08

Market Cap

1.6B

Sector

Technology

ML Signal

SELL

Logo Innoviva Inc.

INVA

Innoviva Inc.

HOLD

Current Price

$23.64

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POET
INVA
Founded
1972
1996
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
POET
INVA
Price
$8.08
$23.64
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$32.80
AVG Volume (30 Days)
28.5M
522.3K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
816.67
EPS
N/A
3.30
Revenue
N/A
$217,217,000.00
Revenue This Year
$848.96
$8.95
Revenue Next Year
$700.00
$12.65
P/E Ratio
N/A
$7.08
Revenue Growth
N/A
62.63
52 Week Low
$3.79
$16.52
52 Week High
$15.50
$25.15

Technical Indicators

Market Signals
Indicator
POET
INVA
Relative Strength Index (RSI) 50.17 53.75
Support Level $5.40 $23.28
Resistance Level $9.14 $24.45
Average True Range (ATR) 1.37 0.63
MACD 0.20 -0.09
Stochastic Oscillator 22.69 38.96

Price Performance

Historical Comparison
POET
INVA

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Share on Social Networks: